Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Cleveland OH, Detroit MI, Hamilton, Cincinnati OH,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy Reactions

for
Allergic Rhinitis, Asthma, Allergic Conjunctivitis
Location: South Euclid OH
Sponsor: University Hospitals Cleveland Medical Center

Sex: All

Age: 5+

Code: NCT01878929

Phase 1, Phase 2, Recruiting

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

for
Multiple Myeloma, Myeloma, Myeloma Multiple
Location: Cleveland OH, Ann Arbor MI, Toronto, Philadelphia PA,
Sponsor: K36 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05651932

Phase 1, Recruiting

Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

for
High Grade Glioma, Glioblastoma
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05565118

Phase 1, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Cleveland OH, Columbus OH, Detroit MI, Ann Arbor MI,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases

for
Spine Metastases, Spine Stereotactic Radiosurgery (sSRS)
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04218617

Phase 2, Recruiting

Efficacy & Safety for LN144 with Pembrolizumab with High Risk Stage IIIb-dResectable Melanoma

for
Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IIID Melanoma
Location: Cleveland OH
Sponsor: James Isaacs, MD

Sex: All

Age: 18+

Code: NCT06190249

Phase 1, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Cleveland OH, Pittsburgh PA, Columbus OH, Ann Arbor MI,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma

for
Lymphoma, Non-Hodgkin Lymphoma, B-Cell
Location: Cleveland OH
Sponsor: Luminary Therapeutics

Sex: All

Age: 18+

Code: NCT05312801

Phase 1, Recruiting

Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer

for
Localized Muscle Invasive Bladder Urothelial Carcinoma,
Location: Cleveland OH
Sponsor: Shilpa Gupta, MD

Sex: All

Age: 18+

Code: NCT05833867

Phase 1, Recruiting

Development of MRF for Characterization of Brain Tumors After Radiotherapy

for
Brain Tumor, Brain Necrosis, Brain Metastases, Glioma
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18 - 60

Code: NCT06101069

Recruiting

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Cleveland OH, Pittsburgh PA, Buffalo NY, Edgewood KY,
Sponsor: LigaChem Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06774963

Phase 1, Recruiting

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

for
Graft Vs Host Disease, Vulvovaginal Signs and Symptoms
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: Female

Age: 18 - 70

Code: NCT06649201

Recruiting

Sacituzumab Govitecan in Recurrent Glioblastoma

for
Recurrent Glioblastoma
Location: Cleveland OH, Austin TX, San Antonio TX
Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All

Age: 18+

Code: NCT04559230

Phase 2, Recruiting

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

for
Relapsed Sarcomas
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT05210374

Phase 1, Recruiting

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

for
Non-Hodgkin Lymphoma, Cytokine Release Syndrome
Location: Cleveland OH
Sponsor: Taylor Brooks

Sex: All

Age: 18 - 65

Code: NCT06447376

Phase 1, Recruiting

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

for
Acute Myeloid Leukemia,
Location: Cleveland OH, Boston MA, Houston TX, Portland OR
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03471260

Phase 1, Phase 2, Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

for
Non Hodgkin Lymphoma, B-cell Non Hodgkin Lymphoma,
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT07225439

Phase 1, Recruiting

Feasibility and Acceptability of Wearable Sensors and ePROs in Early Phase Clinical Trials

for
Cancer
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07541365

Recruiting

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

for
Solid Tumors, Adult
Location: Cleveland OH, Plantation FL, Denver CO
Sponsor: Hutchmed

Sex: All

Age: 18+

Code: NCT07228247

Phase 1, Phase 2, Recruiting